Home Journals Articles Updates About
CN
image
收藏切换
De novo design of highly efficient type-Ⅰ photosensitizer based on π-conjugated oligomer for photodynamic eradication of multidrug-resistant bacterial infections
收藏切换
PDF
Qi Zhaoa, b, 1, Guangchao Qingc, 1, Jie Yub, Ying Liub, Jianliang Shena, Yang Luoc, d, *, Xingjie Zana, *, Shengliang Lib, *
Chinese Chemical Letters | 2024, 35(3) : 108535
Less
收藏切换
Chinese Chemical Letters | 2024, 35(3): 108535
• Communication •
De novo design of highly efficient type-Ⅰ photosensitizer based on π-conjugated oligomer for photodynamic eradication of multidrug-resistant bacterial infections
Full
Qi Zhaoa, b, 1, Guangchao Qingc, 1, Jie Yub, Ying Liub, Jianliang Shena, Yang Luoc, d, *, Xingjie Zana, *, Shengliang Lib, *
Affiliations
  • a State Key Laboratory of Ophthalmology, Optometry and Vision Science, School of Ophthalmology and Optometry, School of Biomedical Engineering, Wenzhou Medical University; Wenzhou Institute, University of Chinese Academy of Sciences; Oujiang Laboratory (Zhejiang Lab for Regenerative Medicine, Vision and Brain Health), Wenzhou 325001, China
  • b College of Pharmaceutical Sciences, Soochow University, Suzhou 215123, China
  • c Center of Smart Laboratory and Molecular Medicine, School of Medicine, Chongqing University, Chongqing 400044, China
  • d College of Life Science and Laboratory Medicine, Kunming Medical University, Kunming 650050, China
Published: 2024-03-15 doi: 10.1016/j.cclet.2023.108535
Outline
收藏切换

Traditional photosensitizers show limited singlet oxygen generation in hypoxic infection lesions, which greatly suppress their performance in antibacterial therapy. Meanwhile, there still is lack of feasible design strategy for developing hypoxia-overcoming photosensitizers agents. Herein, radical generation of π-conjugated small molecules is efficiently manipulated by an individual selenium (Se) substituent. With this strategy, the first proof-of-concept study of a Se-anchored oligo (thienyl ethynylene) (OT-Se) with high-performance superoxide radical (O2•−) and hydroxyl radical (•OH) generation capability is present, and achieves efficient antibacterial activities towards the clinically extracted multidrug-resistant bacteria methicillin-resistant S. aureus (MRSA) and carbapenem-resistant E. coli (CREC) at sub-micromolar concentration under a low white light irradiation (30 mW/cm2). The water-dispersible OT-Se shows a good bacteria-anchoring capability, biocompatibility, and complete elimination of multidrug-resistant bacteria wound infection in vivo. This work offers a strategy to boost type-Ⅰ photodynamic therapy (PDT) performance for efficient antibacterial treatments, advancing the development of antibacterial agents.

Photodynamic therapy  /  Antibacterial  /  Type-Ⅰ photosensitizers  /  Multidrug-resistant bacteria  /  Conjugated oligomers
Qi Zhao, Guangchao Qing, Jie Yu, Ying Liu, Jianliang Shen, Yang Luo, Xingjie Zan, Shengliang Li. De novo design of highly efficient type-Ⅰ photosensitizer based on π-conjugated oligomer for photodynamic eradication of multidrug-resistant bacterial infections[J]. Chinese Chemical Letters, 2024 , 35 (3) : 108535 - . DOI: 10.1016/j.cclet.2023.108535
Full Text
Less
Numerous pathogenic bacterial infections seriously threaten human health throughout the world [1]. It is even worse that bacterial infections with a strong resistance against conventional antibiotics have increased dramatically in the past decade [2–5]. As noted by the World Health Organization (WHO), multidrug-resistant (MDR) bacteria have become the top 10 of worldwide public health crises and are a serious global threat to human health [6]. Thus, there is a timely urgent need to develop a new approach with resistance-free capability for high-performance bacterial eradication.
Given the failure of antibiotics to fight against various resistant bacterial infections, nonantibiotic strategies have been closely on the rise over the past few years to overcome these inefficiencies in treating various drug-resistant bacterial infections [7–13]. Among these nonantibiotic methods, photodynamic therapy (PDT) has received increasing concern due to its advantages of high spatiotemporal precision, ignorable drug resistance, and broad antibacterial spectrum [14–19]. However, most existing PDT agents mainly generate singlet oxygen (1O2) by commonly employing a type-Ⅱ PDT process, which is known as an oxygen-dependent modality and whose applications have been largely limited by the natural hypoxic conditions of infection and biofilms [20–22]. In contrast, type-Ⅰ PDT agents employing electrons to generate radical species such as superoxide radicals (O2•−) and hydroxyl radicals (•OH) show much less dependency on the oxygen level [23–27]. Given the potential of type-Ⅰ PDT, a handful of type-Ⅰ photosensitizers (PSs) have been explored for antibacterial applications in recent years [22,23,28-30]. However, the radical generation efficiency of reported type-Ⅰ PSs is still at a relatively low level, and the feasible molecular design for type-Ⅰ PDT agents is still unknown until now.
Conjugated oligomers that consist of a few similar conjugated units were characterized with strong electron-delocalized and tunable optoelectronic properties. Recent advances in the fields of organic photovoltaics (OPVs) [31,32], organic light-emitting diodes (OLEDs) [33,34], and organic field-effect transistors (OFETs) [35,36] have led to the development of conjugated oligomers. Taking advantage of their light-harvesting and light-amplifying capabilities, conjugated oligomers have also been widely used for biomedical applications, mainly biosensors, imaging, and phototherapy [37–41]. In recent years, conjugated oligomers have been successfully explored as antibacterial PSs due to their high singlet oxygen generation [42–46]. However, these reported conjugated oligomers mainly concentrate on the development of type-Ⅱ PDT, which generally restricted by oxygen level in lesion.
In this work, we developed a conjugated oligomer photosensitizer OT-Se to efficiently boost radical generation capability for eradicating multidrug-resistant bacterial infection (Scheme 1). The molecular design originates from oligo(thienyl ethynylene) (OT-S), which possesses good visible light-harvesting capability with high-performance 1O2 generation [39]. Via individual selenium (Se) anchoring, the O2•− and •OH radical yields of OT-Se were efficiently enhanced through the type-Ⅰ mechanism. In addition, cationic quaternary ammonium salts were conjugated into both ends of OT-Se to provide a reliable bacterial membrane-anchoring function. Both in vitro and in vivo investigations indicated that OT-Se serves as a type-Ⅰ photosensitizer that can photodynamically kill antibiotic-resistant bacteria and achieve complete elimination of wound infection with good biocompatibility. Thus, our study offers a reliable molecular strategy for developing high-performance type-Ⅰ PDT agents and holds great potential in bacterial infection treatments.
The oligo(thienyl ethynylene)s, OT-S and OT-Se, were synthesized according to a synthetic route, as shown in Fig. S1 (Supporting information). OT-S and OT-Se were synthesized via Sonogashira coupling and then anchored with a cationic group quaternary ammonium salt in the two terminals. To achieve a heavy-atom effect, a strong acceptor selenophen was introduced to replace the in-between thiophene of OT-S for building the OT-Se compound (Fig. 1a). The molecular structures of OTs and their intermediates were characterized with nuclear magnetic resonance (NMR) spectroscopy and high-revolution mass spectrometry (Figs. S2–S15 in Supporting information). Both OT-S and OT-Se have good water solubility and show broad absorption from 300 nm to 450 nm with typical blue-green fluorescence emission in the range of 420–650 nm (Fig. 1b). Compared with OT-S, OT-Se shows an approximate 20 nm bathochromic shift in the absorption and emission peaks, with weaker fluorescence intensity under ultraviolet (UV) lamp irradiation (Fig. S16 in Supporting information).
The total reactive oxygen species (ROS) generation performance of OTs was evaluated by measuring the variation in the emission spectra of 2,7-dichlorodihydrofluorescein (DCFH, an ROS indicator) upon white light exposure (400–700 nm, 1 mW/cm2). As shown in Fig. 1c, the 525 nm fluorescence of DCFH treated with OT-S and OT-Se shows an obvious increase with the time of white light irradiation. Importantly, OT-Se shows a more remarkable fluorescence increase than OT-S, implying that OT-Se has a higher total ROS generation capability than OT-S. We then investigated the singlet oxygen (1O2) generation capability of OT-S and OT-Se using 1,3-diphenylisobenzofuran (DPBF, a 1O2 indicator) and methylene blue (MB, a PS standard) and found that the relative 1O2 quantum yields (Φ) of OT-Se (Φ = 0.57) and OT-S (Φ = 0.56) were approximately similar and had comparable 1O2 capability towards MB (Fig. 1d and Fig. S17 in Supporting information). To further explore the type-Ⅰ photochemical reaction of OTs, the superoxide radical (O2•−) and hydroxyl radical (•OH) generation performance was investigated by dihydrorhodamine 123 (DHR123, an O2•− indicator) and hydroxyphenyl fluorescein (HPF, a •OH indicator), respectively. As shown in Figs. 1e–g, upon 320 s of white light irradiation (50 mW/cm2), the O2•− and •OH generation capability of OT-Se is 1.5 times and 1.9 times as much as that of OT-S, respectively. These results demonstrated that incorporating selenium atoms into OTs would augment the intersystem crossing (ISC) efficiency and type-Ⅰ photochemical reaction for radical species generation [47], as summarized in Fig. 1h. The enhancement in radical species generation of OT-Se holds great potential in hypoxia-associated antibacterial and anti-infection applications.
Membrane anchoring can endow photosensitizers with local enrichment in the bacterial cell membrane, which is beneficial for ROS-driven lipid peroxidation and ultimately leads to efficient bacterial death. OT-Se is a typical "end-only" conjugated oligomer with hydrophilic quaternary ammonium salt structures on both ends of the molecule and hydrophobic aromatic acetylene structure in the backbone, thus holding great potential for membrane anchoring. To investigate the interaction between OT-Se and bacteria, the change in zeta potential of E. coli before and after OT-Se treatment was measured (Fig. S18 in Supporting information). The results show that the negative zeta potential of E. coli (−46.8 mV) became positive (+58.9 mV) after 1 min incubation of OT-Se (20 µmol/L) in saline, with a typical positive correlation with the OT-Se concentration, suggesting good bacteria-binding capability. Confocal laser scanning microscopy (CLSM) was further employed to visualize the bacteria-binding performance. As shown in Fig. 1i, green-fluorescent OT-Se could first anchor to the bacterial membrane and then quickly enter the bacterial cytoplasm within 100 s of interaction. Z-series scanning of CLSM further confirmed that OT-Se would completely stain the whole bacteria. These results indicate that OT-Se can rapidly anchor to bacteria and provide a chance for efficient bacterial killing.
Inspired by the good ROS generation capability of OT-Se, we next used the standard plate colony-counting method to evaluate the antibacterial activity of OT-Se towards the Gram-negative bacterium E. coli and the Gram-positive bacterium S. aureus. As shown in Fig. S19 (Supporting information), the death percentage of OT-Se-treated E. coli and S. aureus increased significantly with increasing OT-Se concentration upon 30 mW/cm2 white light irradiation for 30 min, while OT-Se under dark conditions exhibited relatively low antibacterial activities against E. coli and S. aureus. Furthermore, the antibacterial activities of OT-Se against E. coli and S. aureus showed irradiation time-dependent profiles (Fig. S20 in Supporting information). Notably, the minimum bactericidal concentration (MBC) of OT-Se against S. aureus and E. coli was measured to be approximately 80 nmol/L and 2.5 µmol/L, respectively, suggesting that OT-Se has relatively high antibacterial activity compared with the reported PDT agents. In contrast, the heavy-atom-free OT-S showed relatively weak antibacterial activity against the two bacteria (Fig. S21 in Supporting information). The results demonstrated that the enhanced type-Ⅰ PDT activity of OT-Se can afford highly efficient antibacterial capability against both Gram-negative bacteria and Gram-positive bacteria.
To further confirm the antibacterial activity, we performed live/dead staining to visualize the survival condition before and after OT-Se treatment. As shown in Fig. S22 (Supporting information), both OT-Se-treated E. coli and S. aureus display obvious red and orange fluorescence, while the bacteria treated with white light irradiation without OT-Se show almost completely green fluorescence, indicating that the photodynamic effect of OT-Se can induce efficient death towards E. coli and S. aureus. Next, scanning electron microscopy (SEM) was performed to evaluate the morphology change of bacteria after OT-Se treatment. Both E. coli and S. aureus treated with light irradiation in the absence of OT-Se had intact surfaces and morphologies (Fig. S23 in Supporting information). However, after OT-Se treatment plus light irradiation, the cell membranes of the two bacterial strains were seriously destroyed, and showed a certain extent of collapse and punching, thus indicating the interaction of the localized photodynamic effect of OT-Se towards bacteria.
It is widely known that multidrug-resistant bacteria and their infections are the greatest challenges in the clinic and annually cause numerous deaths throughout the world. At present, global scientists in the community of chemistry, pharmaceutical science, and biomedicine are committing themselves to exploring new methods or tracts for overcoming antibiotic resistance problems. Next, we systematically investigated the antibacterial activity of OT-Se against the clinically isolated multidrug-resistant bacteria methicillin-resistant S. aureus (MRSA) and carbapenem-resistant E. coli (CREC). As shown in Fig. 2, approximately 94% of MRSA is killed at 140 nm of OT-Se, and 2.5 µmol/L of OT-Se can kill more than 99.5% of CREC upon 30 mW/cm2 white light irradiation. As noted, the anti-MRSA activity of OT-Se was nearly 17.8 times greater than the anti-CREC capability, suggesting relatively high MRSA-specific antibacterial activity. In contrast, OT-Se has weak antibacterial activities against the two bacteria without light irradiation (Fig. S24 in Supporting information). The growth curve experiment of MRSA and CREC further confirmed the highly efficient antibacterial results of OT-Se under illumination (Fig. S25 in Supporting information). The live/dead staining assay also confirms the highly efficient anti-MRSA and anti-CREC performance of plate-counting experiments. Moreover, SEM and TEM images verified the destructive effect of OT-Se on the cell membrane of MRSA and CREC bacteria through localized ROS generation (Fig. 2 and Fig. S26 in Supporting information). These above results suggest that biocompatible OT-Se with multi-ROS generation has highly efficient antibacterial activity against the multidrug-resistant bacteria MRSA and CREC and holds great potential for eradicating multidrug-resistant bacterial infections.
Motivated by the good in vitro activities against the multidrug-resistant bacteria CREC and MRSA, we further evaluated the in vivo antibacterial performance on a CREC and MRSA infection model of mouse skin (Fig. 3a). All animal experiment protocols were approved by the National Center for Nanoscience and Technology's Institutional Animal Care and Use Committee. With OT-Se treatment plus 30 min irradiation with white light, both CREC- and MRSA-infected wounds showed obvious disappearance of pyosis, and 98% of skin wounds healed after 10 days of treatment (Figs. 3b and e). In contrast, phosphate buffer saline (PBS) and OT-Se alone had relatively slow wound healing performance (60% for PBS; 75% for OT-Se alone) and maintained a slight inflammation phenomenon. The macroscopic area of the infection wound further confirmed the high-performance antibacterial and wound healing capabilities (Figs. 3c and f). Hematoxylin and eosin (H&E) images of wound tissue demonstrate that OT-Se with light irradiation has more preferable skin repair and regrowth than the other two control groups (Fig. 3h and Fig. S27 in Supporting information). These results suggest that OT-Se-based PDT can efficiently eradicate multidrug-resistant bacterial infection to accelerate wound healing.
In vitro cytotoxicity experiments were conducted on normal cells NIH-3T3 and demonstrated that OT-Se shows negligible cytotoxicity towards NIH-3T3 at concentrations of 10 µmol/L, indicating good biocompatibility (Fig. S28 in Supporting information). The biosafety of OT-Se was evaluated by monitoring the weight change of mice after 10 days of treatment. No noticeable weight changes were observed in OT-Se-treated mice (Figs. 3d and g). In addition, H&E staining of the main organs showed nearly negligible inflammatory lesions and organ damage after 10 days of treatment, suggesting that OT-Se has good in vivo biocompatibility and biosafety (Fig. S29 in Supporting information).
In summary, we showed notably boosted radical generation in conjugated oligomers by anchoring a selenium substituent in the backbone and demonstrated their antibacterial infection performances against multidrug-resistant bacteria at sub-micromolar concentrations. Through the selenium substituent, OT-Se has a redshifted absorption but lower fluorescence emission compared to OT-S. More importantly, the O2•− and •OH radical generation of OT-Se was boosted to be 1.5 times and 1.9 times as much as that of OT-S, respectively, indicating the reliable enhancement effect on the type-Ⅰ PDT. Due to their fast bacterial anchoring, OT-Se can be used as a type-Ⅰ photosensitizer to photodynamically kill the clinically extracted antibiotic-resistant bacteria CREC and MRSA at extremely low concentrations. We also demonstrate that OT-Se can successfully eradicate CREC and MRSA bacterial infection and afford efficient wound healing with good in vivo biocompatibility. Our investigation has demonstrated the great promise of OT-Se as a type-Ⅰ PDT agent for clinical antibacterial applications.
Declaration of competing interest
Less
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Acknowledgments
Less
This work was financially supported by the National Natural Science Foundation of China (Nos. 82125022, 82072383, 31800833, 21977081, 52173135 and 22207024), Zhejiang Provincial Natural Science of Foundation of China (No. LZ19H180001), Wenzhou Medical University (No. KYYW201901), and University of Chinese Academy of Science (Nos. WIBEZD2017001-03 and WIUCASYJ2020001).
Supplementary materials
Less
Supplementary material associated with this article can be found, in the online version, at doi:10.1016/j.cclet.2023.108535.
References
Less
[1]
F. Werdin, M. Tenenhaus, H.O. Rennekampff, Lancet 372 (2008) 1860–1862.
[2]
M. Baym, L.K. Stone, R. Kishony, Science 351 (2016) aad3292.
[3]
C. Willyard, Nature 543 (2017) 15.
[4]
X. Li, S. Lee, J. Yoon, Chem. Soc. Rev. 47 (2018) 1174–1188.
[5]
Y. Liu, Y. Li, L. Shi, J. Control. Release 329 (2021) 1102–1116.
[7]
M.F. Chellat, L. Raguz, R. Riedl, Angew. Chem. Int. Ed. 55 (2016) 6600–6626.
[8]
X. Li, H. Bai, Y. Yang, et al., Adv. Mater. 31 (2019) e1805092.
[9]
Y. Wang, Y. Yang, Y. Shi, et al., Adv. Mater. 32 (2020) e1904106.
[10]
Y. Ren, H. Liu, X. Liu, et al., Cell Rep. Phys. Sci. 1 (2020) 100245.
[11]
L. Mei, S. Zhu, Y. Liu, et al., Chem. Eng. J. 418 (2021) 129431.
[12]
G. Qing, X. Zhao, N. Gong, et al., Nat. Commun. 10 (2019) 4336.
[13]
T. Yu, G. Jiang, R. Gao, et al., Expert Opin. Drug Deliv. 17 (2020) 1151–1164.
[14]
B.M. Luby, C.D. Walsh, G. Zheng, Angew. Chem. Int. Ed. 58 (2019) 2558–2569.
[15]
B. Ran, Z. Wang, W. Cai, et al., J. Am. Chem. Soc. 143 (2021) 17891–17909.
[16]
J. Li, Z. Meng, Z. Zhuang, et al., Small 18 (2022) e2200743.
[17]
H. Zhang, C. He, L. Shen, et al., Chin. Chem. Lett. 34 (2023) 108160.
[18]
J. Zuo, E. Zhu, W. Yin, et al., Chem. Sci. 14 (2023) 2139–2148.
[19]
T.F. Li, H.Z. Xu, Y.H. Xu, et al., Mol. Pharm. 18 (2021) 3601–3615.
[20]
D. Hu, L. Zou, W. Yu, et al., Adv. Sci. 7 (2020) 2000398.
[21]
J. Sun, X. Cai, C. Wang, et al., J. Am. Chem. Soc. 143 (2021) 868–878.
[22]
P. Xiao, Z. Shen, D. Wang, et al., Adv. Sci. 9 (2022) 2104079.
[23]
C.C. Yang, M.H. Tsai, K.Y. Li, et al., Int. J. Mol. Sci. 20 (2019) 2072.
[24]
J. Sun, K. Du, J. Diao, et al., Angew. Chem. Int. Ed. 59 (2020) 12122–12128.
[25]
Z. Zhuang, J. Dai, M. Yu, et al., Chem. Sci. 11 (2020) 3405–3417.
[26]
T.C. Pham, V.N. Nguyen, Y. Choi, et al., Chem. Rev. 121 (2021) 13454–13619.
[27]
V.N. Nguyen, Y. Yan, J. Zhao, et al., Acc. Chem. Res. 54 (2021) 207–220.
[28]
J.S. Ni, T. Min, Y. Li, et al., Angew. Chem. Int. Ed. 59 (2020) 10179–10185.
[29]
H. Fan, Y. Fan, W. Du, et al., Nanoscale 12 (2020) 9517–9523.
[30]
W. Li, J. Zhang, Z. Gao, et al., Coordin. Chem. Rev. 471 (2022) 214754.
[31]
H.C. Li, X. Tang, S.Y. Yang, et al., Chin. Chem. Lett. 32 (2021) 1245–1248.
[32]
J. Roncali, Adv. Energy Mater. 11 (2021) 2102987.
[33]
M. Zhang, G. Dai, C. Zheng, et al., Chin. Chem. Lett. 33 (2022) 1110–1115.
[34]
I.P. Koskin, C.S. Becker, A.A. Sonina, et al., Adv. Funct. Mater. 31 (2021) 2104638.
[35]
B. Zhao, B. Gothe, A. Groh, et al., ACS Appl. Mater. Interfaces 13 (2021) 32461–32466.
[36]
O. Gidron, M. Bendikov, Angew. Chem. Int. Ed. 53 (2014) 2546–2555.
[37]
S. Li, Q. Deng, Y. Zhang, et al., Adv. Mater. 32 (2020) e2001146.
[38]
C. Zhou, J.C.S. Ho, G.W.N. Chia, et al., Adv. Funct. Mater. 30 (2020) 2004068.
[39]
M. Yang, H. Zhao, Z. Zhang, et al., Chem. Sci. 12 (2021) 11515–11524.
[40]
Z. Zhang, Q. Yuan, M. Li, et al., Small 17 (2021) e2104581.
[41]
L. Zhou, F. Lv, L. Liu, et al., CCS Chem. 1 (2019) 97–105.
[42]
B. Wang, M. Wang, A. Mikhailovsky, et al., Angew. Chem. Int. Ed. 56 (2017) 5031–5034.
[43]
B. Wang, B.N. Queenan, S. Wang, et al., Adv. Mater. 31 (2019) e1806701.
[44]
H. Wang, W. Zhao, X. Liu, et al., ACS Appl. Bio Mater. 3 (2019) 593–601.
[45]
Z. Zhou, C. Ergene, J.Y. Lee, et al., ACS Appl. Mater. Interfaces 11 (2019) 1896–1906.
[46]
C. Du, D. Gao, M. Gao, et al., ACS Appl. Mater. Interfaces 13 (2021) 27955–27962.
[47]
K. Wen, H. Tan, Q. Peng, et al., Adv. Mater. 34 (2022) 2108146.
Appendix
Less
Year 2024 volume 35 Issue 3
PDF
54
32
Cite this Article
BibTeX
Article Info
doi: 10.1016/j.cclet.2023.108535
  • Receive Date：2023-02-13
  • Online Date：2025-11-20
  • Published：2024-03-15
Article Data
Affiliations
History
  • Received：2023-02-13
  • Revised：2023-05-01
  • Accepted：2023-05-04
Affiliations
    a State Key Laboratory of Ophthalmology, Optometry and Vision Science, School of Ophthalmology and Optometry, School of Biomedical Engineering, Wenzhou Medical University; Wenzhou Institute, University of Chinese Academy of Sciences; Oujiang Laboratory (Zhejiang Lab for Regenerative Medicine, Vision and Brain Health), Wenzhou 325001, China
    b College of Pharmaceutical Sciences, Soochow University, Suzhou 215123, China
    c Center of Smart Laboratory and Molecular Medicine, School of Medicine, Chongqing University, Chongqing 400044, China
    d College of Life Science and Laboratory Medicine, Kunming Medical University, Kunming 650050, China
References
Share
https://castjournals.cast.org.cn/joweb/ccl/EN/10.1016/j.cclet.2023.108535
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family		 属数
Number of
genus		 种数
Number of
species		 占总种数比例
Percentage of
total species (%)		 属
Genus		 种数
Number of
species		 占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT
Links
Articles
Latest Articles
Most Read
Collections
Updates
Events
News
Multimedia
About
About Us
Contact
No. 86 Xueyuan South Road, Haidian District, Beijing
100081
010-62199257
qkjq@cast.org.cn

Copyright © 2025 China Association for Science and Technology. All rights reserved. For all open access content, the relevant licensing terms apply.
Sponsored by the Office of the Leading Group for Cybersecurity and Informatization of CAST, and supported by Science and Technology Review Publishing House